Bakos Annamária, Besenyi Zsuzsanna, Sipka Gábor, Urbán Szabolcs, Hemelein Rita, Kovács László, Pávics László
Általános Orvostudományi Kar, Nukleáris Medicina Intézet,Szegedi Tudományegyetem Szeged, Korányi fasor 6., 6720.
Általános Orvostudományi Kar, Reumatológiai és Immunológiai Klinika,Szegedi Tudományegyetem Szeged.
Orv Hetil. 2020 May 1;161(20):829-838. doi: 10.1556/650.2020.31710.
Introduction: Large-vessel vasculitis has non-specific clinical symptoms, which can delay the diagnosis. Early recognition and treatment of the disease can help to avoid late complications. F-FDG-PET can detect the inflammation of the vessel wall in the early stage of the disease with high sensitivity. CT is used to localize vasculitis. Aim: To examine the performance of F-FDG-PET/CT in patients with suspected large-vessel vasculitis, during relapse and remission, focusing on disease activity and extent. Method: 43 patients were evaluated. They were classified according to the clinical questions: steroid-naive suspected vasculitis, suspected vasculitis on steroid treatment, patients with relapse and in remission. We examined 10 cancer patients in control. We carried out visual and quantitative analysis of the F-FDG uptake of vessel walls. During quantitative evaluation, we determined standardised uptake values (SUVmax) of vessel wall segments compared to liver. Results: We found active disease in 5 patients examined for primary diagnosis, moreover, in 5 patients with relapse. The disease involved 3 or more vessel segments in fifty percent of the active cases. In the visually active group, the SUVmax was significantly lower in patients on steroid treatment than in steroid-naive cases (1.17 ± 0.11 vs. 1.43 ± 0.29; p = 0.005). We confirmed remission in 2 cases after therapy. In the inactive group, we found other types of inflammatory disorders in 8 cases. Conclusion: F-FDG-PET/CT is an effective diagnostic tool for large-vessel vasculitis, and can be used to determine the activity and extent of the disease. Steroid treatment influences the F-FDG-uptake of vessel wall. Orv Hetil. 2020; 161(20): 829-838.
大血管血管炎具有非特异性临床症状,这可能会延迟诊断。疾病的早期识别和治疗有助于避免晚期并发症。F-FDG-PET能够高灵敏度地检测疾病早期的血管壁炎症。CT用于确定血管炎的位置。目的:研究F-FDG-PET/CT在疑似大血管血管炎患者复发期和缓解期的表现,重点关注疾病的活动度和范围。方法:对43例患者进行评估。根据临床问题将他们分类:初诊疑似血管炎未使用类固醇治疗的患者、使用类固醇治疗的疑似血管炎患者、复发患者和缓解期患者。我们纳入10例癌症患者作为对照。我们对血管壁的F-FDG摄取进行了视觉和定量分析。在定量评估期间,我们确定了血管壁节段相对于肝脏的标准化摄取值(SUVmax)。结果:在接受初诊检查的5例患者以及5例复发患者中发现了活动性疾病。在50%的活动性病例中,疾病累及3个或更多血管节段。在视觉上显示为活动性的组中,使用类固醇治疗的患者的SUVmax显著低于未使用类固醇治疗的病例(1.17±0.11对1.43±0.29;p=0.005)。治疗后我们确认2例患者缓解。在非活动性组中,8例患者发现了其他类型的炎症性疾病。结论:F-FDG-PET/CT是大血管血管炎的一种有效诊断工具,可用于确定疾病的活动度和范围。类固醇治疗会影响血管壁的F-FDG摄取。《匈牙利医学周报》。2020年;161(20):829-838。